Trial Profile
Multicenter, Randomized, Double-Blind, Placebo - Controlled, Parallel Group, Efficacy and Safety Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Lixivaptan (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cardiokine
- 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
- 24 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2010 New trial record